DOI QR코드

DOI QR Code

Increased Expression of P2RY2, CD248 and EphB1 in Gastric Cancers from Chilean Patients

  • Aquea, Gisela (Departamento de Ciencias Biomedicas, Facultad de Medicina, Universidad Catolica del Norte) ;
  • Bresky, Gustavo (Departamento de Ciencias Biomedicas, Facultad de Medicina, Universidad Catolica del Norte) ;
  • Lancellotti, Domingo (Departamento de Salud Publica, Facultad de Medicina, Universidad Catolica del Norte) ;
  • Madariaga, Juan Andres (Departamento de Ciencias Biomedicas, Facultad de Medicina, Universidad Catolica del Norte) ;
  • Zaffiri, Vittorio (Departamento de Ciencias Biomedicas, Facultad de Medicina, Universidad Catolica del Norte) ;
  • Urzua, Ulises (Departamento de Clinica, Facultad de Medicina, Universidad Catolica del Norte) ;
  • Haberle, Sergio (Laboratorio de Genomica Aplicada, ICBM, Facultad de Medicina, Universidad de Chile) ;
  • Bernal, Giuliano (Departamento de Ciencias Biomedicas, Facultad de Medicina, Universidad Catolica del Norte)
  • 발행 : 2014.03.01

초록

Background: Gastric cancer (GC) ranks as one of the major causes of mortality due to cancer worldwide. In Chile, it is currently the leading cause of cancer death. Identification of novel molecular markers that may help to improve disease diagnosis at early stages is imperative. Materials and Methods: Using whole-genome DNA microarrays we determined differential mRNA levels in fresh human GC samples compared to adjacent healthy mucosa from the same patients. Genes significantly overexpressed in GC were validated by RT-PCR in a group of 14 GC cases. Results: The genes CD248, NSD1, RAB17, ABCG8, Ephb1 and P2RY2 were detected as the top overexpressed in GC biopsies. P2RY2, Ephb1 and CD248 showed the best sensitivity for GC detection with values of 92.9%, 85.7% and 64.3% (p<0.05), respectively. Specificity was 85.7%, 71.4% and 71.4% (p<0.05), for each respectively.

참고문헌

  1. Wang F, Sun GP, Zou YF, et al (2012). MicroRNAs as promising biomarkers for gastric cancer. Cancer Biomark, 11, 259-67.
  2. Sisik A, Kaya M, Bas G, Basak F, Alimoglu O (2013). CEA and CA 19-9 are still valuable markers for the prognosis of colorectal and gastric cancer patients. Asian Pac J Cancer Prev, 14, 4289-94. https://doi.org/10.7314/APJCP.2013.14.7.4289
  3. Valdez Y, Maia M, Conway EM (2012). CD248: reviewing its role in health and disease. Curr Drug Targets, 13, 432-9. https://doi.org/10.2174/138945012799424615
  4. Wang H, Wen J, Wang H et al (2014). Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival. Int J Clin Exp Pathol, 7, 313-21.
  5. Wang JD, Dong YC, Sheng Z, et al (2007). Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis. Oncology, 73, 238-45. https://doi.org/10.1159/000127421
  6. Xing YN, Yang X, Xu XY, et al (2011). The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression. Hum Pathol, 42, 25-35. https://doi.org/10.1016/j.humpath.2010.05.024
  7. Yasui W, Sentani K, Sakamoto N, et al (2011). Molecular pathology of gastric cancer: research and practice. Pathol Res Pract, 207, 608-12 https://doi.org/10.1016/j.prp.2011.09.006
  8. Yokobori T, Mimori K, Ishii H, et al(2010). Clinical significance of stanniocalcin 2 as a prognostic marker in gastric cancer. Ann Surg Oncol, 260, 2061-7.
  9. Zhao ZS, Chu YQ, Ye ZY, Wang YY, Tao HQ (2010). Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance. Hum Pathol, 5, 686-96.
  10. Zhang ZY, Zhang H, Adell G, Sun XF (2011). Endosialin expression in relation to clinicopathological and biological variables in rectal cancers with a Swedish clinical trial of preoperative radiotherapy. BMC Cancer, 11, 89. https://doi.org/10.1186/1471-2407-11-89
  11. Maia M, DeVriese A, Janssens T, et al (2011). CD248 facilitates tumor growth via its cytoplasmic domain. BMC Cancer, 11, 162. https://doi.org/10.1186/1471-2407-11-162
  12. Li WH, Qiu Y, Zhang HQ, et al (2013). P2Y2 receptor promotes cell invasion and metastasis in prostate cancer cells. Br J Cancer, 109, 1666-75. https://doi.org/10.1038/bjc.2013.484
  13. Li HJ, Wang LY, Qub HN, et al (2011). P2Y2 receptor-mediated modulation of estrogen-induced proliferation of breast cancer cells. Mol Cell Endocrinol, 338, 28-37. https://doi.org/10.1016/j.mce.2011.02.014
  14. Ma G-J, Gu R-M, Zhu M, et al (2013). Plasma post-operative miR-21 expression in the prognosis of gastric cancers. Asian Pac J Cancer Prev, 14, 7551-4. https://doi.org/10.7314/APJCP.2013.14.12.7551
  15. MINSAL (2010). Ministerio de Salud, Guia Clinica Cancer Gastrico. SERIE GUIAS CLINICAS MINSAL. $2^{\circ}$ Edicion. Santiago. 8-9.
  16. Naylor A, Azzam E, Smith S, et al (2012). The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice. Arthritis Rheum, 64, 3334-43. https://doi.org/10.1002/art.34556
  17. Pesti S, Balazs A, Udupa R, et al (2012). Complex formation of EphB1/Nck/Caskin1 leads to tyrosine phosphorylation and structural changes of the Caskin1 SH3 domain. Cell Commun Signal, 10, 36. https://doi.org/10.1186/1478-811X-10-36
  18. Sampieri L, Pena S, Ochoa-Lara M, Zenteno-Cuevas R, Leon-Cordoba K (2010). Expression of matrix metalloproteinases Cordoba K (2010). Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis. World J Gastroenterol, 16, 1500-5. https://doi.org/10.3748/wjg.v16.i12.1500
  19. Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S (2013). Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell, 24, 130-7. https://doi.org/10.1016/j.ccr.2013.05.008
  20. Simonavicius N, Robertson D, Bax D, et al (2008). Endosialin (CD248) is a marker of tumor-associated pericytes in highgrade glioma. Modern Pathol, 21, 308-15. https://doi.org/10.1038/modpathol.3801006
  21. Faria R, Ferreira L, Bezerra R, Frutuoso V, Alves L (2012). Action of natural products on P2 receptors: A reinvented era for drug discovery. Molecules, 17, 13009-25. https://doi.org/10.3390/molecules171113009
  22. Bertazza L, Mocellin S, Marchet A, et al (2009). Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med, 7, 111-9. https://doi.org/10.1186/1479-5876-7-111
  23. Bouche E, Romero-Ortega M, Henkemeyer M, et al (2013). Reelin induces EphB activation. Cell Res, 23, 473-90. https://doi.org/10.1038/cr.2013.7
  24. Choi JH, Ji YG, Lee DH (2013). Uridine triphosphate increases proliferation of human cancerous pancreatic duct epithelial cells by activating P2Y2 receptor. Pancreas, 42, 680-6. https://doi.org/10.1097/MPA.0b013e318271bb4b
  25. He C-Z, Zhang K-H (2013). Serum protein and genetic tumor markers of gastric carcinoma. Asian Pac J Cancer Prev, 14, 3437-42. https://doi.org/10.7314/APJCP.2013.14.6.3437
  26. Heise K, Bertran E, Andia M, Ferreccio K (2009). Incidence and survival of stomach cancer in a high-risk population of Chile. World J Gastroenterol, 15, 185486.
  27. Ingold B, Simon E, Ungethum U, et al (2010). Vascular CXCR4 Expression a Novel Antiangiogenic Target in Gastric Cancer? PLoS ONE, 5, 10087. https://doi.org/10.1371/journal.pone.0010087
  28. Iwatsuki M, Mimori K , Fukagawa T, et al (2010). The Clinical Significance of Vimentin-Expressing Gastric Cancer Cells in Bone Marrow. Ann Surg Oncol, 17, 2526-33. https://doi.org/10.1245/s10434-010-1041-0
  29. Kim SK, Jeon JW, Park JJ, et al (2011). Associations of EPHB1 polymorphisms with hepatocellular carcinoma in the Korean population. Hum Immunol, 72, 916-20. https://doi.org/10.1016/j.humimm.2011.06.014
  30. Kunzli B, Bernlochner MI, Rath S, et al (2011). Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signalling, 7, 231-41. https://doi.org/10.1007/s11302-011-9228-9
  31. Arancibia H, Carvajal C, Bustamante M, et al (2009). Quality of life of patients operated for gastric cancer. Rev Med Chile 137, 481-6.
  32. Bagley R, Rouleau C, St Martin T, et al (2008). Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248. Mol Cancer Ther, 7, 2536-46. https://doi.org/10.1158/1535-7163.MCT-08-0050
  33. Bernal G (2012). Use of RNA isolated from feces as a promising tool for the early detection of colorectal cancer. Int J Biol Markers, 27, 82-9. https://doi.org/10.5301/JBM.2012.9107

피인용 문헌

  1. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer vol.6, pp.1664-3224, 2015, https://doi.org/10.3389/fimmu.2015.00402
  2. Rab17 regulates apical delivery of hepatic transcytotic vesicles vol.29, pp.23, 2018, https://doi.org/10.1091/mbc.E18-07-0433